Is AbbVie's aggressive biotech partnership model sustainable? Learn how its focus on late-stage assets, like Cerevel Therapeutics, shapes its future.
Aaron Brown
·
Industrial startups disrupt manufacturing. Learn growth strategies like using IoT to cut capital costs by 30% and dominate niche markets.
·
AbbVie commits $1.2B to Iambic's AI platform for faster drug discovery. See how AI speeds up identifying new therapies, reducing time and cost.
·
Founders: Avoid costly disputes and SEC penalties. Learn 5 key steps for shareholder agreements, compliance, and audits.
·
Iambic uses AI to speed up drug discovery. Learn how their Iambic Engine and $150M funding are accelerating cancer drug IAM-H1 to trials.
·
·
6 min read
Syngenta faces a 25% talent shortage in biotech. Learn how it's changing recruitment to attract startup-minded specialists & what's next for ag-tech.
·
·
7 min read
Used car SaaS drives 15% sales gains. See how data platforms help dealers boost sales and cut costs. Get ready for data-driven auto retail.
·
·
4 min read
New Buy America rules demand 75% domestic content. See how procurement tech, like AI, helps businesses meet 2026 mandates and avoid supply chain issues.
·
·
8 min read
HANK shows AI's immediate impact on customer service. See how it cuts costs by 25% and boosts satisfaction. Why ignore this change?
·
·
8 min read
How do advocacy groups like Public Citizen challenge big pharma? See 2026's policy changes, including a 15% cost drop for some drugs.
·
·
7 min read
